Cost of Revenue of AMPHENOL CORP /DE/ from 31 Dec 2016 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
AMPHENOL CORP /DE/ quarterly and annual Cost of Revenue in USD history and change rate from 31 Dec 2016 to 31 Dec 2025.
  • AMPHENOL CORP /DE/ Cost of Revenue for the quarter ending 31 Dec 2025 was $3,977,900,000, a 40% increase year-over-year.
  • AMPHENOL CORP /DE/ Cost of Revenue for the twelve months ending 31 Dec 2025 was $14,577,000,000, a 45% increase year-over-year.
  • AMPHENOL CORP /DE/ annual Cost of Revenue for 2025 was $14,577,000,000, a 45% increase from 2024.
  • AMPHENOL CORP /DE/ annual Cost of Revenue for 2024 was $10,083,000,000, a 19% increase from 2023.
  • AMPHENOL CORP /DE/ annual Cost of Revenue for 2023 was $8,470,600,000, a 1.4% decline from 2022.
Source SEC data
View on sec.gov
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Change (%)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Change (%)

AMPHENOL CORP /DE/ Quarterly Cost of Revenue (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $14,577,000,000 $3,977,900,000 +$1,140,700,000 +40% 01 Oct 2025 31 Dec 2025 10-K 11 Feb 2026 2025 FY
Q3 2025 $13,436,300,000 $3,835,100,000 +$1,153,200,000 +43% 01 Jul 2025 30 Sep 2025 10-Q 24 Oct 2025 2025 Q3
Q2 2025 $12,283,100,000 $3,597,000,000 +$1,200,400,000 +50% 01 Apr 2025 30 Jun 2025 10-Q 25 Jul 2025 2025 Q2
Q1 2025 $11,082,700,000 $3,167,000,000 +$999,700,000 +46% 01 Jan 2025 31 Mar 2025 10-Q 25 Apr 2025 2025 Q1
Q4 2024 $10,083,000,000 $2,837,200,000 +$610,100,000 +27% 01 Oct 2024 31 Dec 2024 10-K 11 Feb 2026 2025 FY
Q3 2024 $9,472,900,000 $2,681,900,000 +$531,200,000 +25% 01 Jul 2024 30 Sep 2024 10-Q 24 Oct 2025 2025 Q3
Q2 2024 $8,941,700,000 $2,396,600,000 +$334,400,000 +16% 01 Apr 2024 30 Jun 2024 10-Q 25 Jul 2025 2025 Q2
Q1 2024 $8,607,300,000 $2,167,300,000 +$136,700,000 +6.7% 01 Jan 2024 31 Mar 2024 10-Q 25 Apr 2025 2025 Q1
Q4 2023 $8,470,600,000 $2,227,100,000 +$25,400,000 +1.2% 01 Oct 2023 31 Dec 2023 10-K 11 Feb 2026 2025 FY
Q3 2023 $8,445,200,000 $2,150,700,000 -$84,500,000 -3.8% 01 Jul 2023 30 Sep 2023 10-Q 25 Oct 2024 2024 Q3
Q2 2023 $8,529,700,000 $2,062,200,000 -$70,400,000 -3.3% 01 Apr 2023 30 Jun 2023 10-Q 26 Jul 2024 2024 Q2
Q1 2023 $8,600,100,000 $2,030,600,000 +$5,300,000 +0.26% 01 Jan 2023 31 Mar 2023 10-Q 26 Apr 2024 2024 Q1
Q4 2022 $8,594,800,000 $2,201,700,000 +$116,100,000 +5.6% 01 Oct 2022 31 Dec 2022 10-K 07 Feb 2025 2024 FY
Q3 2022 $8,478,700,000 $2,235,200,000 +$306,600,000 +16% 01 Jul 2022 30 Sep 2022 10-Q 27 Oct 2023 2023 Q3
Q2 2022 $8,172,100,000 $2,132,600,000 +$321,900,000 +18% 01 Apr 2022 30 Jun 2022 10-Q 28 Jul 2023 2023 Q2
Q1 2022 $7,850,200,000 $2,025,300,000 +$375,700,000 +23% 01 Jan 2022 31 Mar 2022 10-Q 28 Apr 2023 2023 Q1
Q4 2021 $7,474,500,000 $2,085,600,000 +$425,200,000 +26% 01 Oct 2021 31 Dec 2021 10-K 07 Feb 2024 2023 FY
Q3 2021 $7,049,300,000 $1,928,600,000 +$340,100,000 +21% 01 Jul 2021 30 Sep 2021 10-Q 28 Oct 2022 2022 Q3
Q2 2021 $6,709,200,000 $1,810,700,000 +$427,000,000 +31% 01 Apr 2021 30 Jun 2021 10-Q 29 Jul 2022 2022 Q2
Q1 2021 $6,282,200,000 $1,649,600,000 +$347,400,000 +27% 01 Jan 2021 31 Mar 2021 10-Q 29 Apr 2022 2022 Q1
Q4 2020 $5,934,800,000 $1,660,400,000 +$188,100,000 +13% 01 Oct 2020 31 Dec 2020 10-K 08 Feb 2023 2022 FY
Q3 2020 $5,746,700,000 $1,588,500,000 +$149,800,000 +10% 01 Jul 2020 30 Sep 2020 10-Q 29 Oct 2021 2021 Q3
Q2 2020 $5,596,900,000 $1,383,700,000 +$16,000,000 +1.2% 01 Apr 2020 30 Jun 2020 10-Q 30 Jul 2021 2021 Q2
Q1 2020 $5,580,900,000 $1,302,200,000 -$28,500,000 -2.1% 01 Jan 2020 31 Mar 2020 10-Q 30 Apr 2021 2021 Q1
Q4 2019 $5,609,400,000 $1,472,300,000 -$37,400,000 -2.5% 01 Oct 2019 31 Dec 2019 10-K 09 Feb 2022 2021 FY
Q3 2019 $5,646,800,000 $1,438,700,000 -$2,100,000 -0.15% 01 Jul 2019 30 Sep 2019 10-Q 23 Oct 2020 2020 Q3
Q2 2019 $5,648,900,000 $1,367,700,000 +$31,100,000 +2.3% 01 Apr 2019 30 Jun 2019 10-Q 24 Jul 2020 2020 Q2
Q1 2019 $5,617,800,000 $1,330,700,000 +$70,700,000 +5.6% 01 Jan 2019 31 Mar 2019 10-Q 24 Apr 2020 2020 Q1
Q4 2018 $5,547,100,000 $1,509,700,000 +$201,100,000 +15% 01 Oct 2018 31 Dec 2018 10-K 10 Feb 2021 2020 FY
Q3 2018 $5,346,000,000 $1,440,800,000 +$206,100,000 +17% 01 Jul 2018 30 Sep 2018 10-Q 25 Oct 2019 2019 Q3
Q2 2018 $5,139,900,000 $1,336,600,000 +$222,700,000 +20% 01 Apr 2018 30 Jun 2018 10-Q 26 Jul 2019 2019 Q2
Q1 2018 $4,917,200,000 $1,260,000,000 +$215,800,000 +21% 01 Jan 2018 31 Mar 2018 10-Q 26 Apr 2019 2019 Q1
Q4 2017 $4,701,400,000 $1,308,600,000 01 Oct 2017 31 Dec 2017 10-K 12 Feb 2020 2019 FY
Q3 2017 $1,234,700,000 01 Jul 2017 30 Sep 2017 10-Q 26 Oct 2018 2018 Q3
Q2 2017 $1,113,900,000 01 Apr 2017 30 Jun 2017 10-Q 31 Jul 2018 2018 Q2
Q1 2017 $1,044,200,000 01 Jan 2017 31 Mar 2017 10-Q 03 May 2018 2018 Q1

AMPHENOL CORP /DE/ Annual Cost of Revenue (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $14,577,000,000 +$4,494,000,000 +45% 01 Jan 2025 31 Dec 2025 10-K 11 Feb 2026 2025 FY
2024 $10,083,000,000 +$1,612,400,000 +19% 01 Jan 2024 31 Dec 2024 10-K 11 Feb 2026 2025 FY
2023 $8,470,600,000 -$124,200,000 -1.4% 01 Jan 2023 31 Dec 2023 10-K 11 Feb 2026 2025 FY
2022 $8,594,800,000 +$1,120,300,000 +15% 01 Jan 2022 31 Dec 2022 10-K 07 Feb 2025 2024 FY
2021 $7,474,500,000 +$1,539,700,000 +26% 01 Jan 2021 31 Dec 2021 10-K 07 Feb 2024 2023 FY
2020 $5,934,800,000 +$325,400,000 +5.8% 01 Jan 2020 31 Dec 2020 10-K 08 Feb 2023 2022 FY
2019 $5,609,400,000 +$62,300,000 +1.1% 01 Jan 2019 31 Dec 2019 10-K 09 Feb 2022 2021 FY
2018 $5,547,100,000 +$845,700,000 +18% 01 Jan 2018 31 Dec 2018 10-K 10 Feb 2021 2020 FY
2017 $4,701,400,000 +$455,000,000 +11% 01 Jan 2017 31 Dec 2017 10-K 12 Feb 2020 2019 FY
2016 $4,246,400,000 01 Jan 2016 31 Dec 2016 10-K 13 Feb 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.